Arcutis Biotherapeutics | 4:持股变动声明-高管 Watanabe Todd Franklin
Arcutis Biotherapeutics | 4:持股变动声明-高管 Watanabe Todd Franklin
Arcutis Biotherapeutics | 4:持股变动声明-董事 Welgus Howard G.
Arcutis Biotherapeutics | 4:持股变动声明-高管 Matsuda Masaru
Arcutis Biotherapeutics | 4:持股变动声明-高管 Edwards Larry Todd
Arcutis Biotherapeutics | 4:持股变动声明-高管 Burnett Patrick
Arcutis Biotherapeutics | 4:持股变动声明-高管 Matsuda Masaru
Arcutis Biotherapeutics | 4:持股变动声明-高管 Burnett Patrick
Arcutis Biotherapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Point72 Asset Management, L.P.(0.2%),Point72 Capital Advisors, Inc.(0.2%)等
Arcutis Biotherapeutics | 4:持股变动声明-董事 Curran Terrie
Arcutis Biotherapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Rubric Capital Management LP(9.38%),David Rosen(9.38%)
Arcutis Biotherapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(7.7%)
Arcutis Biotherapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Morgan Stanley(3.4%)
Arcutis Biotherapeutics | 4:持股变动声明-高管 Matsuda Masaru
Arcutis Biotherapeutics | 4:持股变动声明-高管 Watanabe Todd Franklin
Arcutis Biotherapeutics | 4:持股变动声明-董事 Welgus Howard G.
Arcutis Biotherapeutics | 4:持股变动声明-高管 Burnett Patrick
Arcutis Biotherapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(7.7%)
Arcutis Biotherapeutics | 4:持股变动声明-高管 Edwards Larry Todd
Arcutis Biotherapeutics | 4:持股变动声明-董事 Welgus Howard G.
暂无数据